Insiders at Mirati Therapeutics (MRTX) Make Significant purchases Extending the 90 day Trend

Monday, November 20, 2017 10:15 PM ET

Insiders at Mirati Therapeutics (MRTX) Make Significant purchases Extending the 90 day Trend

Over the last 90 days, the number of insider buy/sell trades at Mirati Therapeutics is above the 272-company peer group average. Bio Therapeutic Drugs peer group saw 342 buy/sell trades during this period for an average of 1.3 transactions per company. The number of shares per buy/sell trade for Mirati Therapeutics insiders was also higher. Within the peer group there were 37,380,021 shares purchased and 20,886,396 shares sold with company insiders acquiring 79,296 shares on average.

Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in composing and writing this story.

Today’s Insider Activity
* Boxer Capital Llc, 10% Owner, bought 400,000 shares
* Broadfin Healthcare Master Fund Ltd, 10% Owner, sold 60,000 shares

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.